Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|---|
Filter | GSE237611 | H5 | |||||||
GSM7634809 |
donor T1DAL_365106, alefacept treated, 104 wk post-treatment, responder (R), single cell RNA-seq
|
SRA | 1 |
|
Stephanie Osmond | Jan 17, 2024 | |||
GSM7634810 |
donor T1DAL_799347, alefacept treated, 104 wk post-treatment, responder (R), single cell RNA-seq
|
SRA | 1 |
|
Stephanie Osmond | Jan 17, 2024 | |||
GSM7634811 |
donor T1DAL_325261, alefacept treated, 104 wk post-treatment, non-responder (NR), single cell RNA-seq
|
SRA | 1 |
|
Stephanie Osmond | Jan 17, 2024 | |||
GSM7634812 |
donor T1DAL_671942, alefacept treated, 104 wk post-treatment, non-responder (NR), single cell RNA-seq
|
SRA | 1 |
|
Stephanie Osmond | Jan 17, 2024 | |||
GSM7634813 |
donor T1DAL_616755, alefacept treated, 104 wk post-treatment, responder (R), single cell RNA-seq
|
SRA | 1 |
|
Stephanie Osmond | Jan 17, 2024 | |||
GSM7634814 |
donor T1DAL_923889, alefacept treated, 104 wk post-treatment, non-responder (NR), single cell RNA-seq
|
SRA | 1 |
|
Stephanie Osmond | Jan 17, 2024 | |||
GSM7634815 |
donor T1DAL_442289, alefacept treated, 104 wk post-treatment, non-responder (NR), single cell RNA-seq
|
SRA | 1 |
|
Stephanie Osmond | Jan 17, 2024 | |||
GSM7634816 |
donor T1DAL_323347, alefacept treated, 104 wk post-treatment, responder (R), single cell RNA-seq
|
SRA | 1 |
|
Stephanie Osmond | Jan 17, 2024 | |||
GSM7634817 |
donor T1DAL_947702, alefacept treated, 104 wk post-treatment, non-responder (NR), single cell RNA-seq
|
SRA | 1 |
|
Stephanie Osmond | Jan 17, 2024 | |||
GSM7634818 |
donor T1DAL_769151, alefacept treated, 104 wk post-treatment, responder (R), single cell RNA-seq
|
SRA | 1 |
|
Stephanie Osmond | Jan 17, 2024 | |||
GSM7634819 |
donor T1DAL_243767, alefacept treated, 104 wk post-treatment, responder (R), single cell RNA-seq
|
SRA | 1 |
|
Stephanie Osmond | Jan 17, 2024 | |||
GSM7634820 |
donor T1DAL_576351, alefacept treated, 104 wk post-treatment, non-responder (NR), single cell RNA-seq
|
SRA | 1 |
|
Stephanie Osmond | Jan 17, 2024 |